Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turkey, Istanbul
No hidden fees – just official clinic prices. Pay at the clinic for Fanconi Anemia treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Fanconi Anemia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Fanconi Anemia treatment journey.
Dr. Zafer Gulbas founded and directs Turkey’s largest Bone Marrow Transplant Center at Anadolu Medical Center. He is a hematologist-oncologist specializing in complex blood cancers and clotting disorders. Dr. Gulbas trained at top global institutions, including MD Anderson and Fred Hutchinson in the USA. He performs autologous and allogeneic transplants for leukemia, lymphoma, and aplastic anemia.
Dr. Kadri Yamac is an internist and hematologist. He earned his medical degree from Ankara University Faculty of Medicine (1976–1982). He completed Internal Medicine training at Gazi University Faculty of Medicine (1984–1989). He then completed a Hematology subspecialty at Gazi University Faculty of Medicine (1990–1993). He became an Associate Professor at Gazi University Faculty of Medicine in 1995. He was promoted to Professor in 2002.
Medical interests: anemias, coagulation disorders, hemochromatosis, chronic lymphocytic leukemia, lymph node diseases, non-Hodgkin lymphoma, Hodgkin lymphoma.
Allogeneic stem cell transplantation is the primary curative treatment for Fanconi anaemia in Turkey. This procedure replaces defective marrow with healthy cells from a matched donor. Specialists often use radiation-free, fludarabine-based conditioning protocols. This reduces toxicity for patients sensitive to standard intensive treatments.
Bookimed Expert Insight: Turkish haematology centres like Anadolu Medical Center maintain a collaboration with Johns Hopkins Medicine. This connection gives patients access to international protocols for rare genetic conditions. Dr Zafer Gulbas has achieved an 81% success rate specifically in complex transplant cases. This suggests that centre volume and international partnerships are vital for high-risk bone marrow failure.
Patient Consensus: Patients note that finding a compatible donor is the most critical early step. They also emphasise that the transplant is a major procedure requiring an experienced haematology team.
Turkish clinics manage Fanconi Anemia by using reduced-intensity conditioning to protect fragile DNA. Specialists avoid radiation and high-dose chemotherapy to prevent severe organ toxicity. Protocols typically use fludarabine and low-dose cyclophosphamide. This approach achieves successful stem cell engraftment while reducing secondary cancer risks.
Bookimed Expert Insight: Turkish haematology centres frequently use multidisciplinary tumour boards to review complex inherited marrow disorders. Dr Zafer Gulbas at Anadolu Medical Center has supervised 3,000+ transplant procedures. This high volume allows clinics to refine low-dose conditioning for rare cases like Fanconi Anemia. Patients benefit from this collective expertise, which is often missing in smaller international centres.
Patient Consensus: Patients emphasise the need for a written conditioning plan before travelling to Turkey. They note that clear communication regarding infection prophylaxis and emergency admission is vital for fragile cases. Many describe feeling more secure when centres provide detailed medication records for post-treatment care.
Turkish centres like Anadolu Medical Center and Memorial Healthcare Group specialise in complex bone marrow failure. These JCI-accredited facilities offer allogeneic transplants and genetic diagnostics. Specialists such as Dr Zafer Gulbas have supervised over 3,000 successful transplant procedures since 2010.
Bookimed Expert Insight: Many centres offer general haematology. However, the experience gap is significant for rare conditions like Fanconi Anaemia. Dr Zafer Gulbas at Anadolu Medical Center has performed over 1,500 bone marrow transplants. His team reports an 81% success rate for autologous transplants. Choosing a centre with this specific volume is vital. It helps manage the meticulous conditioning regimens needed for bone marrow failure.
Patient Consensus: Patients in Turkey suggest prioritising large tertiary hospitals with dedicated genetics departments. They recommend private Istanbul hospital chains for English-speaking coordinators. These chains provide comprehensive blood testing in one location.
Turkish haematology centres provide structured post-transplant follow-up through a hybrid of local monitoring and remote coordination. Patients undergo 6 to 8 weeks of intensive observation in Istanbul or Ankara until engraftment. Follow-up includes JCI-standardised infection prophylaxis. It also includes long-term surveillance for secondary malignancies and endocrine complications.
Bookimed Expert Insight: Turkish haematology specialists have vast practical experience with complex cases. Professor Zafer Gulbas works at Anadolu Medical Center. He has supervised over 3,000 successful transplants since 2010. This high volume allows doctors to refine follow-up protocols. These protocols are specifically for Fanconi Anaemia patients. His clinic also collaborates directly with Johns Hopkins Medicine International for global quality standards.
Patient Consensus: Patients in Turkey note that coordinators manage translation and logistics during recovery. Those returning to Australia emphasise having a local haematology team ready. This team should be ready to handle ongoing blood tests.
Turkish haematology centres provide intensive medical management to stabilise bone marrow function and monitor cancer risks. Specialist teams use androgen therapy, growth factors, and irradiated transfusion support as bridge treatments. Multidisciplinary care at JCI-accredited facilities includes surgical correction of physical anomalies and rigorous oncological screening protocols.
Bookimed Expert Insight: Turkish haematology expertise is highly concentrated in Istanbul. Prof. Dr Zafer Gulbas at Anadolu Medical Center has performed over 3,000 transplants. This volume is critical. High-volume specialists identify subtle marrow changes earlier than general haematologists. They often use bridge therapies like danazol to keep patients stable while searching for HLA-matched donors.
Patient Consensus: Patients highlight that managing this condition in Turkey involves frequent blood count monitoring rather than a quick fix. Families note the importance of coordinating with paediatric specialists who provide intensive inpatient observation during count fluctuations.